Cargando…
3-Year Results of a Member and Physician Intervention to Reduce Risk Associated With Glucocorticoid-Induced Osteoporosis in a Health Plan
BACKGROUND: Accelerated bone loss is a well-known outcome of chronic treatment with glucocorticoids, making glucocorticoid-induced osteoporosis a significant cause of morbidity and a burden on health care resources. Recommendations for prevention and treatment of glucocorticoid-induced osteoporosis...
Autores principales: | Chitre, Mona M., Hayes, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437640/ https://www.ncbi.nlm.nih.gov/pubmed/18439050 http://dx.doi.org/10.18553/jmcp.2008.14.3.281 |
Ejemplares similares
-
Pharmacological Interventions for Glucocorticoid-Induced
Osteoporosis: An Umbrella Review
por: Liang, Haodong, et al.
Publicado: (2023) -
Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015) -
Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017) -
Advances in Glucocorticoid-Induced Osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011) -
Mechanisms of glucocorticoid induced osteoporosis
por: Canalis, E
Publicado: (2004)